Frequency of cardiovascular risk factors before and 6 and 12 months after bariatric surgery

Silva, Maria Alayde Mendonça da; Rivera, Ivan Romero; Barbosa, Emília Maria Wanderley de Gusmão; Crispim, Maria Angélica Correia; Farias, Guilherme Costa; Fontan, A; Bezerra, Rodrigo Azavedo; Sá, Larissa Gabriella de Souza

doi:10.1016/s2255-4823(13)70491-0

Cited by 5 publications

(10 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The prevalence of metabolic syndrome at baseline was 54%. This prevalence was low compared to other studies [17,18], and this may be explained, at least in part, by the relatively low prevalence of dyslipidemia and hypertension in our study cohort. According to the Framingham risk score to estimate the risk of fatal or nonfatal Bariatric surgery was associated with significant improvement in various cardiovascular risk factors after 6 months in our study.…”

Section: Discussioncontrasting

confidence: 86%

“…The number of patients with metabolic syndrome decreased from 156 (87%) to 53 (29%) after a mean follow-up of 3.4 years. Silva et al [17] performed a prospective observational study composed of 96 patients with obesity, among which 86 were women, aged between 18 and 58 years old. At the end of 6 months, bariatric surgery resulted in 80% reduction in the prevalence of metabolic syndrome (69% vs. 14%, P < 0.0001).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Bariatric surgery and cardiovascular outcome

et al. 2020

View full text Add to dashboard Cite

Background Obesity is recognized as a classic risk factor for atherosclerosis and subsequent cardiovascular disease (CVD). Weight loss after bariatric surgery has been associated with reduced CV mortality and total mortality in obese patients. Our aim was to study the impact of bariatric surgery on CV risk profile, cardiac structure, and function postoperatively. Results This prospective longitudinal study included 100 morbidly obese patients at final analysis. All patients were subjected to full clinical, laboratory, and echocardiographic examination at baseline and 6 months after bariatric surgery. The mean age of study population was 37.2 ± 10.49 with BMI of 47 ± 6.82. Females represented 84%. Sleeve gastrectomy and Roux-en-Y gastric bypass were performed in 79% and 21%, respectively. Surgery-related mortality and morbidity were 0.94% and 4.7%, respectively. After 6 months, there were significant decreases in BMI, heart rate, SBP, DBP, and Framingham risk score (P < 0.0001). The prevalence of risk factors decreased as follows: hypertension 24% vs. 12%, P = 0.0005; DM 21% vs. 11%, P = 0.002; dyslipidemia 32% vs. 7%, P < 0.0001; and metabolic syndrome 54% vs. 26%, P < 0.0001. Highly significant (P < 0.0001) decrease in fasting PG and 2 h PP-PG, HbA1c, ASL, ALT, fasting total cholesterol, LDL, TG, and increase in HDL were observed after bariatric surgery. There were significant shortening in QTc interval (P = 0.009), decrease in LV dimensions and LV mass index (P < 0.0001), and increase in LV EF% (P = 0.0003). BMI at follow-up showed significant positive correlation with age, Framingham risk score, and preoperative BMI (r = 0.289, P = 0.0036; r = 0.37, P = 0.0054; and r = 0.31, P = 0.0081, respectively). Conclusion In addition to enabling patients to achieve a substantial weight loss, bariatric surgery provides a myriad of health benefits. Weight reduction was associated with a favorable improvement in cardiovascular risk profile, cardiac structure, and function.

show abstract

Section: Discussioncontrasting

confidence: 86%

Section: Discussionmentioning

confidence: 99%

Bariatric surgery and cardiovascular outcome

et al. 2020

View full text Add to dashboard Cite

show abstract

“…In contrast to the results presented here, Garcia-Marirrodriga et al 19 and Silva et al 21 showed an increase in serum HDL-Chol levels after surgery. However, these authors did not describe the physical activities of patients after surgery, and Silva et al studied a group of 96 patients, including 86 women.…”

Section: Discussioncontrasting

confidence: 99%

Metabolic syndrome resolution by Roux-en-Y gastric bypass in a real world: a case control study

Schmid

Neto

Dias

et al. 2015

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

Metabolic syndroMe resolution by roux-en-y gastric bypass in a real world: a case control study rev assoC med bras 2015; 61 (2) Conflict of interest: noneObjectives: the aim of this study was to evaluate the efficacy of Roux-en-Y Gastric Bypass (RYGB), compared with nonsurgical treatment (NS group), as an instrument for inducing remission of co-morbidities related to Metabolic Syndrome (MetS) in patients with Obesity, grades 2 and 3 (Ob2,3). Methods: two hundred and fifty eight Ob2,3 patients were selected in a retrospective analysis and included in a case control study. MetS was defined as described by the International Diabetes Federation. One hundred and twenty-nine of these patients underwent RYGB (S group), and 129 were assessed as an NS group. Results: at baseline, S and NS groups did not differ in BMI, age, female sex and prevalence of MetS (p>0.05). For the S group the outcomes were a reduction in BMI of 38.1% (p<0.001), waist circumference of 28.6% (p<0.001), fasting plasma glucose of 10.5% (p<0.001), serum LDL-cholesterol of 21.9% (p<0.001) and of 85% in the number of patients with MetS (p<0.001). For the NS group, only a decrease of 4.12%(p=0.047) in triglyceride levels and of 5.9%(p=0.031) in Diastolic Blood Pressure was observed. In the NS group, 98.6% of the patients continued to have MetS. The number needed to treat (NNT) with surgery to resolve one case of MetS was 1.2 (CI 95%: 1.1 -1.4). Conclusion: in the real world, in the South of Brazil, compared with NS treatment and after 1 year of observation, RYGB is highly effective for decreasing the prevalence of MetS.

show abstract

“…Considerando a vivência no pós-operatório da CB, as participantes desta pesquisa expressaram o controle de comorbidades que as acompanhavam anteriormente à submissão ao procedimento. A literatura mostra que a obesidade está diretamente relacionada a outras condições crônicas, especialmente hipertensão arterial sistêmica, diabetes tipo 2, osteoartrose, apneia do sono e doenças cardiovasculares (11) .…”

Section: Discussionunclassified

Vivência de mulheres no pós-operatório da cirurgia bariátrica: estudo fenomenológico

et al. 2016

View full text Add to dashboard Cite

Aim: understand the experience of women in the postoperative period of bariatric surgery. Method: qualitative study based on Social Phenomenology of Alfred Schütz. The study included eight women, whose testimonies were obtained in the period October-December 2012 through interviews with open questions. Results: The category "Rescue of everyday activities" reveals that surgery allowed the control of chronic diseases associated with obesity, autonomy for self-care and daily activities, the rescue of self-esteem and social inclusion. The category "Challenges" shows that women live with the need to adopt healthy eating habits that can enable the achievement and maintenance of the desired weight. Conclusion: Although this study evidences a gain in quality of life of the "bariatriczied" woman, it also underscores the need for a shared and longitudinal care with this clientele by a multidisciplinary team, due to the chronic nature of obesity.

show abstract

Frequency of cardiovascular risk factors before and 6 and 12 months after bariatric surgery

Cited by 5 publications

References 0 publications

Bariatric surgery and cardiovascular outcome

Bariatric surgery and cardiovascular outcome

Metabolic syndrome resolution by Roux-en-Y gastric bypass in a real world: a case control study

Vivência de mulheres no pós-operatório da cirurgia bariátrica: estudo fenomenológico

Contact Info

Product

Resources

About